// App-Quantinova.ai

629P : Sarcopenia, myosteatosis, and weight loss as determinants of survival and toxicity in patients with resectable esophageal and gastroesophageal junction (GEJ) cancer receiving preoperative chemoradiotherapy (CRT)

Researchers

Presenter

  • A.G.Lui

Principal Investigators

  • A.Gallivan

  • M.Iafolla

  • Z.Abdelaziz

  • D.Yusuf

  • S.Ghosh

  • J.Spratlin

  • K.Mulder

  • M.Sawyer

Medical Centers

  • Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Carboplatin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved